Objectives Discuss the history of breast cancer. Describe the pathology of breast cancer and list significant tumor markers. Differentiate IHC testing.

Slides:

Advertisements

Similar presentations

TOP2A IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN UNSELECTED BREAST CANCER Amit Pancholi Molecular Profiling of Breast Cancer: Predictive Markers of Long.

Advertisements

Mammary ductal carcinoma

Breast Cancer An Overview Dr. Christina Tzagarakis-Foster November 9, 2006.

Comparison of Selected Genes in Curtis Breast Grouped by Cancer and Normal Type log2 median-centered intensity 1. Breast (144) 2. Benign Breast Neoplasm.

Development of laboratory models to study Breast Cancer Deborah Holliday Breast Research Group Section of Pathology & Tumour Biology Section of Pathology.

Breast Pathology Helge Stalsberg MD University Hospital of North Norway.

COMPUTATIONAL INTELLIGENCE FOR THE DETECTION AND CLASSIFICATION OF MALIGNANT LESIONS IN SCREENING MAMMOGRAPHY DATA E. Panourgias,

Breast Cancer ECM Visualization using Multiphoton Imaging Jeremy Bredfeldt LOCI, Morgridge Institute for Research.

Pathology Journal Reading

Oncology Assessment and Management of Patients With Cancer Breast Prepared by Dr. Iman Abdullah.

American Journal of Surgical Pathology March, 2007 David J. Dabbs, MD, Rohit Bhargava, MD, and Mamatha Chivukula, MD Int. 簡聖軒 Lobular Versus Ductal Breast.

Breast Cancer Research Presented by Manish Modi Manish Modi Stevens Institute of Technology REU SUMMER 2005.

Herceptin® (trastuzumab) in combination with chemotherapy: pivotal metastatic breast cancer survival data 1.

What is cancer? A cancer is a malignant tumor, which are cells that multiply out of control, destroying healthy tissues (Dictionary)

Presented by: Katarina Bojanić

Breast Cancer By Kajal Haghmoradi.

Metastatic Breast Cancer: One Size Does Not Fit All Clifford Hudis, M.D. Chief, Breast Cancer Medicine Service MSKCC.

Genetic and Molecular Epidemiology

Ductal Carcinoma in situ

Breast Cancer Clinical Cases Daniel A. Nikcevich, MD, PhD SMDC Cancer Center April 20, 2009.

Real world HER2 testing - are they reliable? Result of the planned analysis of the initial 104 cases enrolled by IHC in NSABP B-31 Soonmyung Paik, MD Division.

Prepared by: Hai Lam Lynn Yu Racheal Richie Trina Jones.

Tutorial on Breast Pathology Part I: Ductal and Lobular Neoplasias Thomas J Lawton MD, Director Seattle Breast Pathology Consultants, LLC Seattle, WA.

Breast Cancer and the Environment Taylor Dungjen Beth Rudolph.

Comparing the Positive Effect of Vitamin E and Flouxetine in the Treatment of Hot Flashes in Breast Cancer Patients. Comparing the Positive Effect of.

Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.

Breast Cancer Awareness Marissa Gregg. What is Breast Cancer?  Breast Cancer forms in the breast  It is a tumor in the breast  Breast cancer is the.

Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.

1 Study of Tamoxifen and Raloxifene STAR Larry Wickerham, MD NSABP STAR Project Officer.

CANCER BREAST OVERVIEW Dr. Ehab M.Oraby. INTRODUCTION  Breast is a modified sweat gland between skin and pectoral fascia.

1 Digital Mammography and Computer-Aided Diagnosis.

Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.

Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.

Division of Surgical, Molecular and Ultrastructural Pathology University of Pisa Pisa University Hospital Research Doctorate.

Breast disease MUDr. Petr Šafář, CSc.. Anatomy of female breast.

Breast Cancer By: Christen Scott.

By: Ashley Rodriguez, Yara parada, Briana Mendoza, Jackie Hernandez

Breast Cancer Jeorge Kristoffer R. Duldulao, RN. Breast Cancer A rapid, unregulated growth of abnormal cells originating from the breast tissue.

Breast Cancer Dr. Gehan Mohamed. Introduction Most common female cancer. The incidence of breast cancer increases with age. 80% of cases occur in post-menopausal.

Fibroadenoma Dr. Gehan Mohamed.

A RAY OF HOPE: TAMOXIFEN POWERPOINT PRESENTATION BY NEIL RAKHOLIA

Jacob J. Adler.  The following slides are meant for students to navigate on their own or in small groups.  They are expected to have time to research.

12 th European Congress on Digital Pathology previously European Congress on Telepathology and international Congress on Virtual Microscopy College des.

Case (I) Chemosensitive group. (a) Indistinct margined, oval shaped, hyperdense mass in Rt. UIQ with clustered pleomorphic microcalcifications (b) Nearly.

Digital Mammography and Computer-Aided Diagnosis

Deepam Meditours Medical Assistance Tourism Company We will FIGHT against “BREAST CANCER”……. Want to Join us….

SYMPTOMS | DIAGNOSIS | TREATMENT

Multistep model of breast cancer progression

Public Health Genomics 2012;15:1–10 - DOI: /

Nurdianah HF, Nizuwan A, Muhamad Yusri M

Anatomy of the breast (diagrammatic sagittal section)

Ductal Carcinoma (Breast Cancer)

BREAST CANCER A full classification includes histopathological type, grade, stage (TNM), receptor status, and the presence or absence of genes as determined.

Oncology Assessment and Management of Patients With Cancer Breast

Patterns of ductal carcinoma in situ (DCIS)

Role of the Community Specialist Breast Care Nurse

Marcelo Calil Instituto Brasileiro de Controle do Câncer

IHC-breast cancer subtypes of invasive ductal carcinoma with predominant intraductal component as an insignificant prognostic factor: A register-based.

Figure 1 Overall survival and cause-specific survival after breast conservation treatment with radiation for 1003 patients with mammographically detected.

سرطان الثدي Breast Cancer

سرطان الثدي Breast Cancer

The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer

J.T. Stranix, M.J. Kwa, R.L. Shapiro, J.L. Speyer

Program Goals. Single vs Dual HER2 Blockade for Metastatic HER2-Positive Breast Cancer.

Cysteine cathepsins (proteases)—On the main stage of cancer?

FAK overexpression in invasive human breast cancer and DCIS

(Handling and Evaluation of Breast Cancer Biopsy)

In situ analysis of human breast tissue shows the down-regulation of Spry isoforms in breast cancer. In situ analysis of human breast tissue shows the.

Presentation transcript:

Objectives Discuss the history of breast cancer. Describe the pathology of breast cancer and list significant tumor markers. Differentiate IHC testing from FISH testing for HER2 markers. List the treatment options for metastatic breast cancer. Explain how monoclonal antibodies function. Learn how to administer Herceptin ® (trastuzumab) to patients. Understand the nurse’s role in HER2 testing and follow-up treatment of metastatic breast cancer. Discuss the history of breast cancer. Describe the pathology of breast cancer and list significant tumor markers. Differentiate IHC testing from FISH testing for HER2 markers. List the treatment options for metastatic breast cancer. Explain how monoclonal antibodies function. Learn how to administer Herceptin ® (trastuzumab) to patients. Understand the nurse’s role in HER2 testing and follow-up treatment of metastatic breast cancer.

Breast Cancer Origins Breast profile: A.Ducts B.Lobules C.Dilated section of duct to hold milk D.Nipple E.Fat F.Pectoralis major muscle G.Chest wall/rib cage Enlargement: A.Normal duct cells B.Basement membrane C.Lumen (center of duct) Breast profile: A.Ducts B.Lobules C.Dilated section of duct to hold milk D.Nipple E.Fat F.Pectoralis major muscle G.Chest wall/rib cage Enlargement: A.Normal duct cells B.Basement membrane C.Lumen (center of duct)

Non-Invasive versus Invasive Cancer Normal Cells Non-Invasive Cells Invasive Cells Normal Cells Non-Invasive Cells Invasive Cells

Types of Breast Cancer Ductal Carcinoma in situ (DCIS) Lobular Carcinoma in situ (LCIS) Invasive Ductal Carcinoma (IDC) Invasive Lobular Carcinoma (ILC)